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Abstract: Reactive oxygen species (ROS), includ-
ing hydrogen peroxide (H2O2), induces injury of
endothelium in a variety of pathophysiological con-
ditions, such as inflammation, aging, and cancer.
In our study, we characterized the signaling path-
way linking oxidative stress induced by sublethal
concentrations of H2O2 to p53 in primary human
endothelial cells through the interferon (IFN)-in-
ducible gene IFI16. Induction of IFI16 by H2O2
was concentration- and time-dependent (maximum
at 50 M, 6 h after treatment) and down-regulated
by pretreatment with N-acetyl-L-cysteine, which
acts as an antioxidant. This pathway is a general
response to ROS and not specific to H2O2 treat-
ment, as two other ROS-generating compounds,
i.e., S-nitroso-N-acetylpenicillamine and tert-butyl
hydroperoxide, were equally capable to induce
IFI16. Moreover, IFI16 up-regulation is a result of
protein accumulation, as expression of corre-
sponding mRNA, assessed by real-time polymerase
chain reaction, was not affected. To investigate the
mechanism of IFI16 accumulation, cells were in-
cubated for 6 h in the presence of H2O2 or IFN-,
and then cycloheximide was added to inhibit fur-
ther protein synthesis. The half-life of IFI16 pro-
tein was found to be significantly increased in
H2O2-treated cells compared with IFN--treated
cells (t1/2120 min vs. >30 min in H2O2- vs.
IFN--treated cells, respectively). An increase of
IFI16 was accompanied by interaction with p53
phosphorylated at its N terminus, as shown by im-
munoprecipitation experiments. Moreover, bind-
ing to IFI16 resulted in its transcriptional activa-
tion as shown by an increase in the activity of a
reporter gene driven by p53-responsive sequences
derived from the p21WAF1 promoter, along with an
increase in the p21 mRNA and protein levels. Al-
together, these results demonstrate a novel role of
IFI16 in the signal transduction pathway that leads
to p53 activation by oxidative stress in endothelial
cells. J. Leukoc. Biol. 77: 820–829; 2005.
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INTRODUCTION
The human IFI16 gene, originally identified as a target of
interferons (IFN)-/ and , is a member of the HIN200
family, which includes myeloid nuclear differentiation antigen,
absent in melanoma 2, IFIX in humans, and Ifi202a, Ifi202b,
Ifi203, Ifi204, D3 genes in mice [1–4]. The findings that IFI16
protein and its mouse homologues p202 and p204 interact with
p53, Rb, E2F, activated protein 1, and nuclear factor-B
proteins lead to the hypothesis that it may regulate the function
of different transcription factors [2, 3, 5–11]. More recently, a
role of IFI16 in the apoptosis pathway has been postulated by
the findings that the PYRIN domain, which is commonly found
among cell death-associated proteins, has been located in its
N-terminal [12].
Since its original cloning, IFI16 has been considered spe-
cific for hematopoietic cells [13]. However, further investiga-
tion demonstrated that in normal adult human tissues, it is
expressed in a highly restricted pattern in selected cells within
certain organs [14, 15]. Prominent IFI16 expression is seen in
vascular endothelial cells from blood and lymph vessels and in
stratified squamous epithelia, suggesting its possible link to
inflammation in addition to hematopoiesis. As IFI16 modulates
transcriptional activation by p53, it may regulate endothelial
and epithelial cell physiology through this molecular pathway.
Consistent with this hypothesis, transduction of IFI16 into
human umbilical vein endothelial cells (HUVEC) with a herpes
simplex virus (HSV)-derived replication-defective vector effi-
ciently suppressed endothelial migration, invasion, and forma-
tion of capillary-like structures in vitro [16]. In parallel, sus-
tained IFI16 expression inhibited HUVEC cell-cycle progres-
sion, accompanied by significant induction of p53, p21, and
hypophosphorylated pRb. These findings, with the observa-
tion that HUVEC, immortalized by human papillomavirus
type 16 (HPV16) E6/E7 oncogenes, became resistant to
antiangiogenic and antiproliferative activity caused by
IFI16 overexpression, suggest a relevant role of IFI16 in the
p53 transduction pathway.
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Reactive oxygen species (ROS), including superoxide anion,
hydrogen peroxide (H2O2), and hydroxyl radical, are generated
in an enormous variety of normal metabolic processes, as they
are released from several cell types [17–19]. Accumulation of
excess ROS, which is toxic to cells, can cause oxidative stress,
leading to damage to proteins, nucleic acid, and cell mem-
branes. DNA damage triggers a variety of signaling pathways
that lead to apoptosis or to DNA damage repair that is coupled
with cell-cycle regulation [20–23]. The endothelium is highly
sensitive to injury caused by ROS, including H2O2. ROS may
cause endothelial activation, dysfunction, or death, depending
on dose and exposure time. Low concentrations of ROS may
activate intracellular signaling systems, which protect endo-
thelial cells against inflammatory response. One junction of
such pathways is controlled by p53, which functions as a
potent transcription factor [20–23]. Normally, p53 is present at
low levels in the cytoplasm as a result of its association with the
murine double minute (MDM2) protein, a ubiquitin ligase that
modifies p53 in its C-terminal domain [24, 25]. Cellular stress
induces phosphorylation of its N-terminal domain and achieves
p53 activation by inhibiting MDM2 binding and the nuclear
export of p53 [24–28]. This phosphorylation has been corre-
lated with enhanced induction and functional activation of p53
manifest as transcription of its target p21WAF1.
Understanding the cellular responses to oxidative stress will
provide useful insights into the mechanisms of many patho-
physiological states, such as inflammation, ischemia-reperfu-
sion, diabetes, hypertension, atherosclerosis, and sepsis [29].
In the present study, the regulation and functional role of IFI16
in response to oxidative stress was investigated. The results
show that upon oxidative stress, IFI16 is up-regulated, and its
interaction with p53 leads to transcriptional activation of p53-
dependent genes, such as p21WAF1.
MATERIALS AND METHODS
Cell cultures and reagents
HUVEC were isolated from cannulated human umbilical veins by treatment
with collagenase and maintained in complete endothelial growth medium 2
(EGM-2; Clonetics, San Diego, CA), containing 2% fetal bovine serum, human
recombinant vascular endothelial growth factor, basic fibroblast growth factor,
human epithelial growth factor, insulin growth factor, hydrocortisone, ascorbic
acid, heparin, and GA-1000 (gentamycin and amphotericin B, 1 g/ml),
according to the recommendations of the supplier. Each culture was used up
to five population doublings. The cells were seeded into 100 mm culture dishes
coated with 0.2% gelatin and grown under 5% CO2 at 37°C in medium,
renewed every 3–4 days. S-nitroso-N-acetylpenicillamine (SNAP) and tert-
butyl hydroperoxide (tBHP) were purchased from Sigma-Aldrich (St. Louis,
MO) and used as indicated at a concentration of 50 M and 0.2 mM,
respectively. Monoclonal antibodies (mAb) against p53 and p21WAF1 (p21)
were purchased from Santa Cruz Biotechnology (CA), mAb against p53 Ser15,
from Cell Signaling Technology (Beverly, MA), and mAb against human actin,
from Chemicon International (Temecula, CA). Rabbit polyclonal monospecific
anti-IFI16 antibodies were produced and purified as described previously [14].
For detection of intracellular reactive ROS level, 1 103 HUVEC were seeded
in four-well chamber slides and grown for 24 h in their optimal medium (as
described above). For N-acetyl-L-cysteine (NAC) treatment, the pH of a 0.4
mol/L aqueous stock solution of NAC (Sigma-Aldrich) was adjusted to 7.4 with
NaOH, sterilized by filtration, and diluted in EGM-2 medium to give a final
concentration of 30 mol/L. HUVEC were treated with 30 mol/L NAC for 60
min before treatment with H2O2, as indicated in Results. IFI16 protein half-life
studies were performed by treating cells with H2O2 (50 M) or IFN- (1000
IU/ml) for 6 h. Cycloheximide (CHX; 120 g/ml) was then added to inhibit
further protein synthesis. Cells were harvested at 30 min and 1, 2, and 4 h after
CHX addition. IFI16 protein expression levels were then analyzed by Western
blot.
Retroviral expression vectors
The retroviral vector pBabe-puro, containing the HPV16 E6/E7 open-reading
frame, was kindly provided by Massimo Tommasino (International Agency for
Research on Cancer, Lyon, France). High-titer retrovirus containing superna-
tants (5106 IU/ml) was generated by transient transfection of second-
generation retrovirus producer Phoenix cells and used to infect the cells as
described previously by Pear et al. [30]. After infection, HUVEC were selected
in 0.2 m/ml puromycin for 10 days and designated E6/E7 HUVEC.
Recombinant adenovirus preparation and
HUVEC infection
The pAC-CMV IFI16, containing the human IFI16 cDNA linked to a FLAG-
tag at the NH2-terminal, was cotransfected together with pJM17 into 293 cells
as described in the instruction manual (Microbix Biosystems Inc., Toronto,
Ontario, Canada). Recombinant viruses from individual plaques, purified to
homogeneity by three rounds of limiting dilution, were assessed for virus titer
by plaque formation on the 293 complementing line with agar overlay as
suggested by the manual. Recombinant AdVIFI16 was tested for IFI16 ex-
pression by Western blotting, using an anti-FLAG antibody (Sigma-Aldrich).
For cell transduction, postconfluent HUVEC were washed once with phos-
phate-buffered saline (PBS) and incubated with AdVIFI16 or AdVLacZ at a
multiplicity of infection (moi) of 50 in EGM. After 60 min at 37°C, the virus
was washed off, and fresh, low-serum medium was added. Cells were cultured
for 36 h before use in the experiments.
Plasmids and luciferase assay
p53RELuc and mutated p53 (mutp53)RELuc plasmids contain two copies of a
wild-type p53 (wtp53) binding sequence (5- CGAATTCGAACATGTCCGAA-
CATGTTGAGATCTGCC-3) or two copies of a mutp53 binding sequence
(5-CCGAATTCGAAAATTTCCGAATCCTTTGAGATCTGCC-3), respectively,
subcloned in the pGL3-promoter plasmid, harboring simian virus 40 (SV40)
minimal promoter (Promega, UK).
Equal amounts (4 g) of each reporter plasmid (harboring firefly Luc cDNA)
along with 0.15 g pRLSV40 plasmid (harboring Renilla Luc cDNA) included
as a control for transfection efficiency were introduced into HUVEC cells by
Lipofectamine Plus (Gibco, Grand Island, NY). Twenty-four hours later, cells
were infected with recombinant AdVIFI16 or AdVLacZ viruses and then
treated or untreated with H2O2. After 24 h incubation, cells were assayed for
chemiluminescence using the dual luciferase reporter system as suggested by
the manufacturer’s instructions (Promega). Chemiluminescence was measured
using the Lumino luminometer (Stratec Biomedical Systems, Birkenfeld, Ger-
many). For all cotransfection treatment studies, values were normalized by
dividing values for firefly Luc expressed as relative light units by values
obtained from Renilla Luc. The resulting luciferase activity is expressed as fold
induction relative to basal levels measured in cells transfected with p53RELuc
and infected with AdVLacZ, which was set at 1.
Real-time reverse transcriptase-polymerase
chain reaction (RT-PCR)
Total RNA was extracted with GenElute mammalian total RNA kit (Sigma-
Aldrich). Total RNA (1 g) was reverse-transcribed, after 10 min of denatur-
ation at 70°C, in 20 l reaction mixture containing 500 M of each deoxy-
unspecified nucleoside 5-triphosphates, 2.5 M random nonamers, 20 U
RNase inhibitor, and 20 U enhanced avian RT (all from Sigma-Aldrich). The
reaction mixture was incubated at 25°C for 15 min and 45°C for 50 min.
Real-time RT-PCR was performed on a GeneAmp 7000 sequence detection
system (Applied Biosystems, Foster City, CA). IFI16 expression was deter-
mined with a commercial gene expression assay from Applied Biosystems
(Assay-on-Demand: IFI16, Assay No. HS00194261_m1). The housekeeping
gene -actin (Assay-on-Demand: -actin, Assay No. HS99999903_m1) was
used to normalize for variations in cDNA. PCR on each sample was performed
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in triplicate in a 25-l vol containing 1 l diluted cDNA (1:10), 12.5 l 2
TaqMan universal PCR master mix (Applied Biosystems), and 1.25 l 20
Assay-on-Demand mix. The thermocycler parameters were 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The results were
analyzed with a standard curve model.
Western blotting analysis
For crude extract preparation, cells were lysed in 2% sodium dodecyl sulfate
(SDS)-lysis buffer containing 50 mM Tris-HCl, pH 6.8, 100 mM dithiothreitol
(DTT), 2% SDS, and 10% glycerol with the addition of protease and phospha-
tase inhibitors [0.2 mM phenylmethylsulfonyl fluoride (PMSF), 1 g/ml pep-
statin, 0.1 mM benzamidine, 2 g/ml aprotinin, 1 g/ml leupeptin, 1 mM
sodium vanadate, 1 mM sodium fluoride]. Insoluble material was removed by
centrifugation at 13,000 rpm for 5 min. Protein concentration was determined
by the Bio-Rad Dc protein assay (Bio-Rad Laboratories, Hercules, CA).
Proteins were separated on 5%, 8.5%, or 10% SDS polyacrylamide gel
transferred onto a polyvinylidene difluoride membrane (Millipore, Bedford,
MA) according to the instruction manual. The membrane was blocked in a
blocking solution [10 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 0.1% Tween-20, 5%
(w/v) low-fat dry milk] overnight at 4°C and incubated with affinity-purified
anti-IFI16 rabbit polyclonal antibody, p53, p53 Ser15, actin, and p21. Appro-
priate secondary antibodies conjugated with horseradish peroxidase conjugate
were used (Sigma-Aldrich), and the chemiluminescence reaction was visual-
ized by enhanced chemiluminescence (SuperSignal, Pierce, Rockford, IL),
according to the manufacturer’s instructions. Densitometry was performed by
scanning the radiographs and then analyzing the bands with Quantity One
software (Bio-Rad Laboratories).
Immunoprecipitation
Cells were washed in cold PBS, harvested, and centrifuged to collect the pellet,
which was then incubated for 15 min on ice with a cytoplasmic isolation buffer
[10 mM Hepes (pH 7.6), 60 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF,
0.5% Nonidet-P40 (NP-40), protease inhibitor cocktail (Sigma-Aldrich)]. Fol-
lowing centrifugation, the nuclear pellets were collected by removing the
supernatant containing the cytoplasmic extract, washed in cytoplasmic isola-
tion buffer without NP-40, centrifuged, and incubated for 10 min on ice with
a nuclear isolation buffer [20 mM Tris-HCl (pH 8.0), 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, 25% glycerol, protease inhibitor
cocktail (Sigma-Aldirch)]. Supernatants containing the nuclear extracts were
collected and stored at –70°C. Nuclear extracts (10 g proteins) were incu-
bated in a binding buffer [10 mM Tris-HCl (pH 7.9), 50 mM NaCl, 0.5 mM
EDTA, 1 mM DTT, 7.5 mM MgCl2] with antibodies of interest for 50 min at
20°C, and the immune complex was collected with protein G –Sepharose beads
(Sigma-Aldrich) for 2 h at 4°C. The beads were washed six times with wash
buffer [10 mM Tris-HCl (pH 7.9), 50 mM NaCl, 0.5 mM EDTA, 1 mM DTT,
7.5 mM MgCl2, 1% NP-40], and the proteins were eluted with Laemmli sample
buffer.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described previously [31] with radiolabeled oligonu-
cleotides containing a consensus wtp53 binding site derived from the p21
promoter (wtp53, 5-GCCGAATTCGAACATGTCCGAACATGTTGAGAT-
CTGCC-3) or a mutp53 binding site (mutp53, 5-GCCGAATTCGAAAATT-
TCCGAATCCTTTGAGATCTGCC-3). Briefly, the oligonucleotide probes
were labeled with [-32P]adenosine 5-triphosphate (Amersham, Little Chal-
font, UK) and T4 polynucleotide kinase, according to the user’s protocol, and
finally, column-purified on G-25 Sephadex (Bio-Rad Laboratories). Supershifts
were performed using affinity-purified anti-IFI16 rabbit polyclonal antibody or
normal rabbit serum as control.
Immunofluorescence
HUVEC, treated for 2 h with increasing H2O2 concentrations as indicated,
were washed twice with prewarmed Hank’s balanced salt solution and incu-
bated with 5 mol/L 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA;
Molecular Probes, Eugene, OR) for 30 min at 37°C. Immunofluorescence was
assessed with an Olympus 1X70 laser confocal microscope, and images were
captured with Fluoview, version 2.0.
RESULTS
IFI16 up-regulation by H2O2 occurs in a p53-
independent pathway in HUVEC
ROS production following oxidative stress has been recognized
as a key chemical event that regulates the signal transduction
pathways, which ultimately control gene expression and post-
translational modification of proteins [19–22]. To investigate
the physiological significance of the IFI16 protein in mediating
the response to oxidative stress, its expression was analyzed in
proliferating HUVEC treated with low H2O2 concentrations. To
this end, HUVEC were treated with 10 M, 50 M, or 250 M
H2O2 concentrations and incubated with DCFH-DA, a redox-
sensitive dye that accumulates in the mitochondria and exhib-
its green fluorescent staining when oxidized to 2,7-dichlo-
rofluorescein. This technology has been widely used as a
sensor for intracellular ROS detection [32]. As shown in Fig-
ure 1A, HUVEC treated for 2 h with increasing concentrations
of H2O2 exhibited weak green fluorescent staining at 10 M,
which increased to a maximum at 50 M and 250 M con-
centration. As expected, untreated cells did not display any
staining. As 250 M H2O2 resulted in partial cell cytotoxicity
at 24 h after treatment (data not shown), the concentration of 50
M was chosen for further investigations. Time-course exper-
iments revealed that upon treatment with 50 M H2O2, IFI16
started to increase as early as 30 min after treatment, reached
a plateau at 6 h, and decreased at 24 h (Fig. 1B). When
HUVEC were treated for 6 h with increasing concentrations of
H2O2, ranging from 1 M to 50 M (Fig. 1C), IFI16 was barely
detectable in untreated cells, increased at 10 M, and re-
mained at high levels with 50 M. Comparable levels of IFI16
expression were observed upon human IFN- (1000 IU/ml)
treatment. To prove that this pathway is a general response to
ROS and not specific to H2O2 treatment, HUVEC were treated
for 6 h with two other ROS-generating compounds, i.e., SNAP
and tBHP [33, 34], and IFI16 expression was analyzed by
immunoblotting. As shown in Figure 1D, both compounds
induced IFI16 levels comparable with those observed with
H2O2, demonstrating that IFI16 induction is a general response
to ROS.
NAC, a general antioxidant and glutathione precursor that
alters the redox state of cells, has been used to investigate the
role of ROS in numerous biological and pathological processes
[35]. To confirm the ROS capability to trigger IFI16 expression,
HUVEC pretreated for 1 h with NAC were incubated for 6 h
with H2O2 (50 M), and the extracts were analyzed for IFI16
expression. As shown in Figure 2A (lane 3), pretreatment of
endothelial cells with NAC prevented IFI16 accumulation,
suggesting a direct role of ROS in IFI16 induction.
Previous reports demonstrated a direct interaction of IFI16
with p53 [11]. However, it is not known whether IFI16 depends
on functional p53 for its stimulation, i.e., if it belongs to the
growing list of p53-inducible genes. To answer this question,
HUVEC were transduced with recombinant retroviruses ex-
pressing the E6 and E7 genes of HPV16, known to inactivate
p53 and pRb pathways [36]. E6 and E7 gene expression was
confirmed by real-time RT-PCR (data not shown). E6/E7-
HUVEC were then treated with H2O2 (50 M) or left untreated,
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and IFI16 expression levels were determined. As shown in
Figure 2B, untreated E6/E7-HUVEC displayed IFI16 expres-
sion levels comparable with H2O2-treated parental cells, and
no further induction was detected after oxidative stress. As
expected, p53 protein was undetectable in the extracts from
E6/E7-HUVEC, as interaction with HPV16 E6 results in sub-
stantially enhanced degradation of p53 [33]. Altogether, these
results demonstrate that IFI16 induction by H2O2 is indepen-
dent from functional p53.
A discrete sequence within the 5-untranslated region of the
IFI16 gene, containing an IFN-responsive element, has been
shown to be critical for its IFN-induced transcriptional activa-
tion [37]. To clarify the mechanisms of IFI16 induction by
H2O2, its expression was examined at the mRNA level. To this
purpose, HUVEC were stimulated with H2O2 (50 M), and at
different time-points, IFI16 mRNA levels were analyzed by
real-time RT-PCR. As positive control, HUVEC were exposed
to IFN- (1000 IU/ml). As expected, IFI16 mRNA was up-
Fig. 1. Effect of H2O2 on ROS generation and induction of IFI16 in HUVEC. (A) HUVEC treated with 10, 50, or 250 M H2O2 for 2 h were incubated with
DCFH-DA for 30 min at 37°C; cells were washed twice with PBS and analyzed by confocal microscopy. (B) HUVEC (2.5104/cm2) were incubated with 50 M
H2O2 for the indicated times. The whole cell lysates were collected and analyzed by Western blotting (WB) using specific antibodies to IFI16 or -actin as control.
(C) HUVEC (2.5104/cm2) were incubated for 18 h with increasing concentrations of H2O2 or IFN- (1000 U/ml). The whole cell lysates were collected and
analyzed by Western blotting using specific antibodies to IFI16 or -actin as control. (D) HUVEC (2.5104/cm2) were incubated with 50 M H2O2, 0.2 mM tBHP,
and 50 M SNAP for 6 h, and whole cell extracts were analyzed by immunoblotting. Each experiment has been repeated at least three times, and one representative
is reported.
Fig. 2. Effects of NAC or HPV16 E6/E7 oncoproteins on IFI16 induction by H2O2. (A) HUVEC (2.510
4/cm2) were treated with 50 M H2O2 for 6 h in the
absence or presence of 30 M NAC. The whole cell lysates were collected and analyzed by Western blotting (WB) using specific antibodies to IFI16 or -actin
as control. (B) HUVEC or E6/E7 HUVEC (2.5104/cm2) were incubated for 6 h with 50 M H2O2. The whole cell lysates were collected and analyzed by Western
blotting using specific antibodies to IFI16, p53, or -actin as control. Each experiment has been repeated at least three times, and one representative is reported.
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regulated at 6 h after IFN- treatment (about fourfold) when
compared with untreated cells (Fig. 3A). By contrast, H2O2
treatment had only a marginal effect on IFI16 mRNA levels
(	1.5-fold of induction) at all time-points tested, suggesting
that IFI16 accumulation is mainly a result of post-translational
mechanisms.
To further confirm that IFI16 induction by H2O2 is attrib-
uted to an increase in protein stability, we investigated the
effect of oxidative stress on its half-life. To this end, cells were
treated with H2O2 or IFN- for 6 h, and then CHX (120 g/ml)
was added to inhibit new protein synthesis. Extracts were
harvested at the indicated times and separated by SDS-PAGE,
and protein half-life was determined by immunoblotting. As
shown in Figure 3B (left panel), IFN--treated cells exhibited
IFI16 half-life of less than 30 min, as the IFI16 protein is
barely detectable at 30 min after CHX addition. By contrast,
IFI16 half-life in H2O2-treated cells was significantly in-
creased, being detectable at 2 h after CHX treatment (Fig. 3B,
right panel). Taken together, these results demonstrate that
H2O2 differentially regulates IFI16 protein induction com-
pared with IFN- and does not affect its transcriptional acti-
vation but rather stabilizes and accumulates the protein at the
post-transcriptional level.
In vivo interaction between IFI16 and p53
Previous studies have shown that IFI16 directly binds to the
C-terminal region of p53 and augments its transcriptional
activation [11, 38]. Cellular stresses, such as oxidative stress,
induce p53 phosphorylation in its N-terminal domain and
achieve p53 activation by inhibiting MDM2 binding and nu-
clear export [24–27]. Based on the finding that H2O2 induces
IFI16 accumulation, to verify whether this increase corre-
sponded to a gain of function, such as p53 binding and tran-
scriptional activation, reciprocal coimmunoprecipitation ex-
periments were performed. Nuclear extracts from H2O2-treated
HUVEC were immunoprecipitated with antibodies against
IFI16 or p53 and samples immunoblotted with antibodies
against p53 or IFI16, respectively. As shown in Figure 4 (lane
4), anti-IFI16 polyclonal antibodies immunoprecipitated en-
dogenous p53, and no bands were observed with the control
antibody (lane 3). When the nuclear extracts were immunopre-
cipitated with anti-p53 and immunoblotted with anti-IFI16
antibodies, a migrating band with a molecular weight corre-
sponding to the B IFI16 isoform was observed (lane 8). By
contrast, only barely detectable bands were detected with
immunoprecipitates from untreated cells (lanes 2 and 6).
Phosphorylation within or close to the N-terminal domain of
p53 is clearly involved in regulation of its stability by inter-
fering with MDM2 binding [24, 25]. To determine whether
IFI16 interacts with a phosphorylated form of p53, thus con-
tributing to its stabilization, nuclear extracts from H2O2-treated
HUVEC were immunoprecipitated with anti-IFI16 antibodies,
and samples were immunoblotted with anti-Ser15 p53 antibod-
ies. As shown in Figure 4 (lane 10), p53 bound to IFI16 is
indeed phosphorylated within its N-terminal domain at the
Ser15 residue. DNase I treatment of H2O2-treated HUVEC
lysates did not affect immunoprecipitation, suggesting that the
Fig. 3. Effect of H2O2 on de novo IFI16 mRNA and
protein synthesis. (A) HUVEC (2.5104/cm2) were left
untreated or treated for increasing times with 50 M
H2O2 or for 6 h with IFN- (1000 U/ml). Total RNA was
extracted, reverse-transcribed, and analyzed by real-time
RT-PCR for IFI16 or -actin expression using commer-
cial gene expression assays from Applied Biosystems.
The housekeeping gene -actin was used to normalize for
variations in cDNA. We assigned the value of 1 to the
normalized IFI16 level on untreated cells. Each reaction
was performed in triplicate, and the histograms represent
the mean 
 SEM of three independent experiments. (B)
HUVEC (2.5104/cm2) were treated for 6 h with H2O2
(50 M; right panel) or IFN- (1000 IU/ml; left panel).
CHX (120 g/ml) was added, and cell extracts were
harvested at the indicated times. Aliquots (20 g protein)
of whole cell extracts were separated by SDS-PAGE and
analyzed by Western blotting. Each experiment has been
repeated at least three times, and one representative is
reported. **, P 	 0.01, One-way ANOVA with Bonfer-
roni’s multiple comparison test (GraphPad Prism 4.0).
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proteins reside in the same complex, rather than interact
through their DNA (data not shown).
H2O2 treatment accumulates IFI16 in the p53-
DNA binding complex
We next tested whether upon H2O2 treatment, IFI16 and p53
can interact while p53 is bound to DNA. Gel shift assays were
performed using double-stranded oligonucleotides derived
from the p21 promoter containing wtp53 binding sites and
nuclear extracts from HUVEC treated with H2O2 (50 M). As
shown in Figure 5, a specific protein DNA complex was
observed with labeled wtp53 oligonucleotide that could be
competed with a 200-fold excess of cold wtp53 but could not be
competed with mutp53 oligonucleotide containing mutations in
the p53 binding sequences. As expected, untreated cells con-
tained only barely detectable nuclear p53 activity. Addition of
the polyclonal rabbit anti-IFI16 antibodies inhibited specific
binding of p53 to DNA (lane 4), and addition of normal rabbit
serum had no effect. These findings are consistent with those
previously reported by Johnstone et al. [11], showing that
addition of anti-IFI16 mAb inhibits binding of p53 to DNA
rather than generating supershift of the migrating band.
Effect of IFI16 on p53 transcriptional activity
p53 is a sequence-specific transcription factor that binds to
DNA as a tetramer and activates or represses transcription
from a large, ever-increasing number of genes [39]. We there-
fore set out to determine if IFI16 overexpression in HUVEC
without H2O2 exposure would lead to its binding to phosphor-
ylated p53 and an increase of its transcriptional activity. IFI16
overexpression was achieved by infecting HUVEC with Ad-
VIFI16 for 24 h as shown in Figure 6A. As reported earlier,
p53 expression levels were also increased as a consequence of
IFI16 transduction (Fig. 6A) [15, 38]. Nuclear extracts were
immunoprecipitated with anti-FLAG mAb to distinguish exog-
enous IFI16 or with unrelated mAb as control. The immuno-
precipitates from AdVIFI16- and AdVLacZ-infected cells were
then immunoblotted with anti-p53 or anti-p53Ser15 antibod-
ies. As shown in Figure 6B, anti-FLAG antibody immunopre-
cipitated p53, and no bands were observed with the control
antibody. Consistent with previous results, p53 bound to IFI16
is phosphorylated on Ser15 and recognized by the specific
antibodies.
To evaluate the effect of IFI16 overexpression on p53, a
luciferase assay using the p53RELuc or mutp53RELuc re-
porter constructs, containing tandem repeats of the canonical
or mutp53 binding site, respectively, was performed. Tran-
siently transfected cells were left untreated or treated with
H2O2 (50 M) or were infected with AdVIFI16 or AdVLacZ
recombinant viruses, and luciferase activity was measured 24 h
Fig. 4. In vivo interaction of IFI16 with p53 in
H2O2-treated HUVEC. Nuclear extracts were pre-
pared from HUVEC (2104/cm2) left untreated
(lanes 1, 2, 5, 6) or treated for 6 h with 50 M H2O2
(lanes 3, 4, 7–10), and immunoprecipitations (IP)
were performed using antibodies to IFI16 (lanes 2
and 4), p53 (lanes 6 and 8), unrelated mAb (lanes
5 and 7), and normal rabbit serum (NRS; lanes 1
and 3). Bound proteins were separated by SDS-
PAGE, and the presence of p53 (lanes 1–4), IFI16
(lanes 5–8), and p53-Ser15 (lanes 9, 10) was de-
tected by Western blotting (WB) with the indicated
antibodies. Each experiment was performed twice,
and one representative is reported.
Fig. 5. Effect of H2O2 on IFI16 and p53 interaction at the DNA level. Nuclear
extracts from HUVEC (2.5104/cm2) treated for 6 h with H2O2 (50 M) were
incubated with 32P-labeled oligonucleotide containing consensus p53 binding
sites to form a specific complex. Unlabeled competitor oligonucleotides (200-
fold excess) containing wtp53 consensus site or point mutations within the p53
sites that abolished p53 binding (mutp53) were added as indicated by  or –.
Supershift experiments were performed with polyclonal rabbit anti-IFI16 an-
tibodies or normal rabbit serum (NRS) used as a control. Each experiment has
been repeated three times, and one representative is reported.
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later. As shown in Figure 6C, HUVEC, transfected with the
p53RELuc construct, infected with AdVLacZ, and treated with
H2O2, displayed fourfold activation compared with untreated
HUVEC transfected with the same construct, demonstrating
that ROS-dependent IFI16 accumulation leads to transactiva-
tion of the p53-responsive sequences. By contrast, IFI16 over-
expression generated higher levels of luciferase activity (sev-
enfold) independently from H2O2 treatment, demonstrating that
IFI16, per se, is sufficient to stimulate the reporter activity
driven by the p53-responsive sequence and does not require
other signals provided by oxidative stress. That this transacti-
vation is mediated by p53 is further confirmed by the finding
that AdVIFI16 was unable to induce any increase in enzymatic
activity when HUVEC cells were transfected with the
mutp53RELuc reporter construct bearing the mutp53 binding
site.
To assess the physiological response of the cell to the
activation of the p53-responsive elements upon sustained
IFI16 expression, the mRNA and protein levels of a down-
stream p53 gene, i.e., p21, were evaluated. HUVEC were
infected with AdVIFI16 or AdVLacZ, and p21 mRNA and
protein levels were measured by real-time RT-PCR or immu-
noblotting, respectively. Consistent with the results obtained in
transfection experiments, sustained expression of IFI16 pro-
duced an increase in p21 mRNA (Fig. 7A) and p21 protein
(Fig. 7B), suggesting that IFI16 is sufficient, per se, to activate
p53 transcriptional activity and expression of downstream
genes.
DISCUSSION
Oxidative stress resulting from an excessive generation of ROS
has been implicated as an important mechanism that modu-
lates various signaling pathways and contributes to endothelial
dysfunction [17–20]. To defend themselves against DNA oxi-
dation induced by ROS, proliferating cells arrest their cell
cycle to prevent the mutated DNA from being replicated and
transferred to daughter cells. Formation of ROS is not always
associated with cell damage but is also induced during many
physiologic, cellular processes, including the regulation of
signal transduction, gene expression, and proliferation [20–
22]. Therefore, depending on the concentration, the molecular
species, and the subcellular localization, ROS exerts two phys-
iopathological effects: damage to various cell components and
activation of specific signaling pathways.
Fig. 6. IFI16 binds phosphorylated p53 in the absence of oxi-
dative stress and triggers transactivation of the p53-responsive
sequences. (A) HUVEC (2104/cm2) were infected for 24 h with
AdVIFI16 or AdVLacZ (moi 50:1), and nuclear extracts were
analyzed by Western blotting (WB) with the indicated antibodies.
(B) Nuclear lysates were immunoprecipitated with anti-FLAG
mAb or unrelated mAb of the same isotype (control Ab). Bound
proteins were separated by SDS-PAGE, and the presence of p53
or p53-Ser15 was detected by Western blotting with the indicated
antibodies. (C) p53RELuc or mutp53RELuc reporter constructs,
containing tandem repeats of the canonical or mutp53 binding
site, respectively, upstream of the luciferase gene, were trans-
fected into HUVEC (2.5104/cm2). Twenty-four hours later,
cells were left untreated, treated with H2O2 (50 M), or infected
with AdVIFI16 or AdVLacZ (moi 50:1). After an additional 24 h,
protein extracts were assessed for luciferase activity. The result-
ing luciferase activity is expressed as fold induction relative to
basal levels measured in cells transfected with p53RELuc and
infected with AdVLacZ, which was set at 1. The data shown are
the values (
SEM) from three independent experiments performed
in triplicate. *, P 	 0.05; **, P 	 0.01, One-way ANOVA with
Bonferroni’s multiple comparison test.
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Immunohistochemical analysis performed in our [14] and
other laboratories [15] demonstrated that the human IFI16
gene, in addition to hematopoietic tissues, is highly expressed
in endothelial cells. By using a reliable HSV-derived replica-
tion defective vector to efficiently transduce IFI16 into primary
HUVEC, we have previously observed that its sustained ex-
pression inhibited tube morphogenesis and proliferation, ac-
companied by significant induction of p53, p21, and hypophos-
phorylated Rb [16].
In this study, the physiological significance of the IFN-
inducible gene IFI16 in mediating the cellular response to
oxidative stress induced by sublethal H2O2 concentrations was
examined. We found that H2O2 produced rapid accumulation
of IFI16. This was not dependent on functional p53 and pRb
proteins, as similar induction was observed in HPV16 E6/E7-
immortalized HUVEC. Regulation of IFI16 accumulation by
H2O2 appears to be the result of its redox activity, as two other
compounds, i.e., SNAP and tBHP, known to generate ROS
intracellularly [33, 34], caused an IFI16 increase as well.
Moreover, this increase was inhibited by addition of NAC, a
source of sulfhydryl groups in cells and scavenger of free
radicals as it interacts with ROS, such as OH° and H2O2 [35].
The activity of IFI16 could be regulated at the transcrip-
tional level. However, the results obtained demonstrate that
following oxidative stress caused by low H2O2 concentrations,
IFI16 induction is a consequence of protein accumulation
rather than transcriptional activation. This hypothesis rises
from the observation that IFI16 mRNA, evaluated by real-time
RT-PCR, displayed a modest increase compared with that from
untreated HUVEC. By contrast, but consistent with the results
previously reported by Clarke et al. [37], a significant increase
in transcriptional activation of the IFI16 promoter and its
mRNA level was observed following IFN treatment. Further
support to these conclusions came from the finding that inhi-
bition of the novo protein synthesis achieved by CHX addition
did not affect the levels of IFI16 protein and down-regulating
IFI16 induction by IFN-. Thus, low H2O2 concentrations
sufficient to induce intracellular ROS accumulation and IFNs
exploit different mechanisms to accumulate IFI16 protein.
A number of DNA-damaging treatments, including H2O2,
hypoxia, and depletion of ribonucleotide pools, increase the
level of p53 by post-transcriptional regulation [38]. More-
over, it has been demonstrated that IFI16 directly binds to
the C-terminal region of p53 and augments p53-mediated
transcriptional activation [11]. Our studies now extend the
role of IFI16 by showing that it is also involved in p53
transcriptional activation by oxidative stress. These findings
demonstrate a possible link between gene induction follow-
ing H2O2 stimulation and p53-mediated cellular events.
Although the physiological significance of the IFI16-p53
interaction is still under investigation, the finding that IFI16
binds p53 phosphorylated at its N terminus upon H2O2
treatment suggests that it bona fide contributes to its stabi-
lization and transcriptional activation. ROS has been impli-
cated in DNA damage by genotoxic agents such as UV and
ionizing radiation or oxidative stress. Subsequent accumu-
lation of ROS-damaged DNA is a critical event during
carcinogenesis and aging [40]. Cellular stresses induce p53
phosphorylation in its N-terminal domain [24 –26]. Several
mechanisms for stress-induced p53 phosphorylation have
been identified including DNA-dependent protein kinase
[41], ataxia teleangiectasia mutated (ATM) kinase [42], and
the Ataxia Teleangiectasia and Rad-3-related kinase [43].
These kinases represent a subgroup of the phosphatidylino-
sitol kinase superfamily that broadly functions in response
to DNA damage or control of the cell cycle. IFI16 contains
four potential phosphorylation consensus motifs (S/TQ) for
ATM kinase, namely at positions 153, 239, 241, and 628.
Fig. 7. IFI16 overexpression stimulates an increase of p21 mRNA and protein levels. (A) HUVEC (2.5104/cm2) were left untreated, treated with 50 M H2O2,
or infected with AdVIFI16 or AdVLacZ (moi 50:1) for 24 h. Total RNA was extracted, reverse-transcribed, and analyzed by real-time RT-PCR for p21 or -actin
mRNA expression using commercial gene expression assays from Applied Biosystems. The housekeeping gene -actin was used to normalize for variations in
cDNA. We assigned the value of 1 to the normalized p21 level on untreated and uninfected cells. (B) HUVEC (2.5104/cm2) were left untreated, treated with 50
M H2O2, or infected with AdVIFI16 or AdVLacZ (moi 50:1) for 24 h. The whole cell lysates were collected and analyzed by Western blotting (WB) using specific
antibodies to p21 or -actin as control. Each experiment has been repeated three times, and one representative is reported. **, P 	 0.01, One-way ANOVA with
Bonferroni’s multiple comparison test.
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The finding that anti-IFI16 antibodies immunoprecipitate
from the lysates of H2O2-treated HUVEC the ATM kinase in
addition to p53 (data not shown) suggests that IFI16 may
help to stabilize p53 by recruiting this kinase into the
complex. Our results are to some extent consistent with
those reported by Xin et al. [44], showing that ectopic
expression of IFI16 in human prostate cancer cell lines
leads to up-regulation of p21 and contributes to senescence-
associated, irreversible growth arrest. IFI16 overexpression
in endothelial cells does not lead to senescence or apoptosis
but to growth arrest in G1 and G2/M phases accompanied by
an increase of p21 [16]. On the contrary, Kwak et al. [45]
reported that the inhibition of endogenous IFI16 expression
by small, interfering RNA in a tumor cell line, U2OS,
expressing high levels of endogenous IFI16, induces
p21WAF1 mRNA and protein expression through p53 and
results in cell-cycle arrest. In subsequent studies, however,
the same investigators [38] demonstrated that overexpres-
sion of IFI16 in the MCF7 carcinoma cell line enhanced p53
transcriptional activity accompanied by p21Waf1 activation
in cells exposed to ionizing radiation. These controversial
results clearly indicate that IFI16 activity may dramatically
change depending on the cell type and experimental system.
In summary, the data presented here demonstrate that oxi-
dative stress leads to accumulation of the IFN-inducible pro-
tein IFI16, binding to phosphorylated p53 on Ser-15, and
transcription of the p53 target gene p21WAF1. These data
suggest a novel role for IFI16 in the response of endothelial
cells to oxidative stress.
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